Reduction of tumorigenicity of SMMC-27721 hepatoma cells by vascular endothelial growth factor antisense gene therapy

doi:10.3748/wjg.v7.i1.22

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2799)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

370

HTML

2183

Figures (1-6)

246

Sum=2799

Feb 15, 2001 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Feb 15, 2001; 7(1): 22-27
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.22

Full Size Figure Download Figure

Figure 3 PCR amplification of genomic DNA from SMMC-7721 antisense, sense VEGF clone. Lane 1: Marker; Lane 2: SMMC-7721/sense VEGF clone showed of neo gene 790 bp; Lane 3: SMMC-7721/antisense VEGF clone showed neo gene 790 bp, U6 cassette 260 bp; Lane 4: SMMC-7721/pLXSN clone showed neo gene 790 bp

Citation: Tang YC, Li Y, Qian GX. Reduction of tumorigenicity of SMMC-27721 hepatoma cells by vascular endothelial growth factor antisense gene therapy. World J Gastroenterol 2001; 7(1): 22-27
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/22.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i1.22